Fig. 3From: Screening and verification of long noncoding RNA promoter methylation sites in hepatocellular carcinomaThe Kaplan–Meier analysis of grouped HCC patients by OS-related lncRNA promoter methylation model. a The survival analysis of HCC patients with high tumor clinical stage by OS-related lncRNA promoter methylation model. b The survival analysis of HCC patients with low tumor clinical stage by OS-related lncRNA promoter methylation model. c The survival analysis of HCC patients with high pathological grade by OS-related lncRNA promoter methylation model. d The survival analysis of HCC patients with low pathological grade by OS-related lncRNA promoter methylation model. e The survival analysis of HCC patients (age ≥ 65) by OS-related lncRNA promoter methylation model. f The survival analysis of HCC patients (age < 65) by OS-related lncRNA promoter methylation model. g The survival analysis of HCC patients (female) by OS-related lncRNA promoter methylation model. h The survival analysis of HCC patients (male) by OS-related lncRNA promoter methylation model. i The survival analysis of HCC patients with high T stage by OS-related lncRNA promoter methylation model. j The survival analysis of HCC patients with low T stage by OS-related lncRNA promoter methylation model. k The survival analysis of HCC patients with tumor-free status by OS-related lncRNA promoter methylation modelBack to article page